UEMS Medical Specialty
Oncology & FSMP
Oncology nutrition and Food for Special Medical Purposes (FSMP): glycolysis-restricted formulas, anti-tumour nutritional support, haematological support, and CDMO-grade medical food manufacturing.
10
dossiers
Glycolysis-Restricted FSMP (Oncology Nutrition)
Medical Foods and Foods for Special Medical Purposes: Regulatory Frameworks and Clinical Nutrition Across Key Regions
Navigating the complex and divergent regulatory frameworks for medical foods in the US and FSMPs in the EU/GCC makes consistent product development, labelling, and market access a significant hurdle for specialized clinical nutrition.
Glycolysis-Restricted FSMP (Oncology Nutrition)
Foods for Special Medical Purposes in Oncology: Nutrition Support & Oral Mucositis Adjunct
Developing clinically substantiated Foods for Special Medical Purposes (FSMPs) and medical foods for cancer patients is challenging due to diverse nutritional needs, metabolic derangements, and specific treatment toxicities like oral mucositis, requiring regulatory diligence and demonstrated efficacy.
Glycolysis-Restricted FSMP (Oncology Nutrition)
The Glucose Paradox in Oncology Nutrition: High-Glycemic Medical Foods and Cancer Outcomes
Current sugar-dominant oncology medical foods may inadvertently fuel tumor growth and worsen metabolic dysfunction in cancer patients. Developing nutritionally complete, low-glycemic formulations that support anabolism without pro-oncogenic effects is a critical challenge.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Ketogenic Interventions in Neurodegeneration: Mechanisms, Clinical Efficacy, and Therapeutic Challenges
Developing clinically robust and compliant ketogenic interventions for neurodegenerative diseases requires overcoming challenges related to variable metabolic responses, sustained therapeutic ketosis, and precise delivery of ketone bodies or precursors in diverse patient populations.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Food Supplements and Medical Foods in Brain Function: A Mechanism-Anchored Evidence Map
Formulators face significant challenges in developing evidence-based brain health supplements due to a lack of clear, mechanism-anchored frameworks for evaluating ingredient efficacy and quality of supporting human data across diverse brain function domains.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Glioblastoma: Epidemiology, Pathology, Molecular Biology, and Therapeutic Landscape
Developing effective glioblastoma therapies is hampered by the tumor's aggressive proliferation, profound intratumoral heterogeneity, and the inherent difficulty in delivering therapeutic agents across the blood-brain barrier to the highly immunosuppressive microenvironment.
Catecholamine Homeostasis & Executive Function
Psychological State and Cancer: Modulatory Roles in Progression and Outcomes
Developing targeted therapies that address the modulatory effects of chronic psychological stress and associated neuroendocrine pathways on tumor progression and patient outcomes in oncology remains a complex challenge.
Glycolysis-Restricted FSMP (Oncology Nutrition)
Technologies and Ingredients for Glycolysis-Restricted Medical Foods in Oncology Nutrition
Developing glycolysis-restricted Foods for Special Medical Purposes (FSMP) for oncology patients is challenged by cancer cachexia, patient dysgeusia, and the need for advanced solutions in lipid-based formulation and product stability.
Intracellular Defense & IV-Alternatives
Personalized mRNA Neoantigen Vaccines: Efficacy and Safety in Melanoma and PDAC
Developing personalized mRNA neoantigen vaccines requires rapid, custom manufacturing workflows within a narrow therapeutic window, presenting significant logistical and scale-up complexities for widespread clinical adoption.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Ketogenic Diet-Specified Interventions in Neurodegenerative Disease Mechanisms
Developing a formulation that achieves consistent and measurable ketosis while optimizing bioavailability and tolerability in neurodegenerative conditions is a key challenge.
No dossiers match the selected MeSH topic in this page. Try another tag or clear the filter.
Custom Formulation Available
Need a Dossier Built Around Your Molecule?
Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.